Alnylam Pharmaceuticals | Diversity Employer
ABOUT ALNYLAM
Our Science Is Changing the Way Medicine Treats DiseaseTM
Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines. Founded in 2002 by a team of distinguished life sciences leaders, Alnylam’s vision is to harness the potential of RNAi therapeutics to transform the lives of people living with diseases for which there are limited or inadequate treatment options. Our pioneering work has delivered the world’s first and only approved RNAi therapeutics—ONPATTRO® (patisiran) in 2018, GIVLAARI® (givosiran) in 2019, OXLUMO® (lumasiran) in 2020, and AMVUTTRA® (vutrisiran) in 2022. We are advancing a deep pipeline of innovative RNAi-based medicines in four therapeutic areas: genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases.
What’s in a Name?
AL-NY-LAM. Our name may not be the easiest to pronounce, but once you learn it, you’ll never forget it. Alnylam is derived from “Alnilam,” the bright center star in the constellation Orion’s belt, which has been used by navigators for thousands of years and symbolizes our passion for discovery.
RNAi Therapeutics—An Innovative New Class of Medicines
Medicines based on RNAi work by “silencing” or disabling the production (“expression”) of the genes that cause specific diseases. In doing so, RNAi therapeutics work “upstream” of most other classes of medicines, such as small molecules and monoclonal antibodies, by targeting the “root” genetic cause of a disease rather than its symptoms. To learn more about our science, click here.
RNAi is the core discovery that forms the therapies Alnylam is developing. It is recognized as a major scientific breakthrough—but how does it work, exactly?
Vision, Mission, and Values
Our Vision - Harnessing a revolution in biology for human health®.
Our Mission - Build a top-tier, global, independent biopharmaceutical company founded on RNAi.
Our Core Values - Commitment to People, Innovation & Discovery, Sense of Urgency, Open Culture, and Passion for Excellence.
CAREERS AT ALNYLAM
Join Our Team and Grow With Us
At Alnylam, we are driven by our mission to translate the Nobel Prize-winning discovery of RNA interference (RNAi) into an innovative, new class of medicines. We’re motivated in this endeavor by the bravery and perseverance of people with unmet medical needs who live with rare and genetic diseases. They are the focus of our efforts, and we exist as a company because of them. That knowledge and commitment to patients is present in everything we do, every day.
At The Forefront of What’s Next
For Patients
Our goal, which is well underway, is to become a world-class biopharmaceutical company that can independently develop and deliver innovative medicines based on RNAi to patients worldwide. We have a deep pipeline of early to late stage investigational therapies, and 2018 marked the approval of our first medicine—the world’s first RNAi therapeutic. Even though we’ve been around since 2002, we’re just getting started!
For Employees
We are growing quickly and hiring across North America, Europe, Asia, and Latin America for a wide variety of roles. We’re seeking smart, passionate, “change the world” kind of people who are ready to say, “challenge accepted.” Our 1,500 (and counting!) employees are building a diverse, equitable, inclusive, and high-performing global organization that celebrates team achievement and recognizes individual contributions.
We’re at the forefront of what’s next for patients, and perhaps your career also.
Search among Alnylam Pharmaceuticals jobs
Jobs: 1 - 10 of 37 |
Director, Market Access, BeNeLux
Cambridge, Massachusetts
Work_Category - hybrid Description Overview The Market Access capability is of critical importance to Alnylam, and the company aims to be an innovator in this area. Our goal is to achieve and maintain appropriate pricing and market access t...
24h
Job Type | Full Time |
Director, Field Force Training Lead
Cambridge, Massachusetts
Work_Category - hybrid Description Overview Alnylam (Nasdaq: ALNY) is delivering on a bold vision to turn scientific possibility into reality, with a robust RNA interference (RNAi) therapeutics platform. As the pioneer in RNAi and the leadi...
24h
Job Type | Full Time |
Cambridge, Massachusetts
Work_Category - virtual Description Overview This role will be responsible to develop and execute local brand plans and tactical plans in the Nordics with focus on driving the overall management of selected Alnylam products. Acting as field...
24h
Job Type | Full Time |
Cambridge, Massachusetts
Work_Category - hybrid Description Overview The Director, Device Platform Management manages a team of Scientists/Engineers to develop and execute implementation strategy for primary containers, devices, and combination products at Alnylam....
1d
Job Type | Full Time |
Associate Director, Clinical Trial Oversight
Cambridge, Massachusetts
Work_Category - virtual Description Responsibilities: The Associate Director, Clinical Trial Oversight will provide strong leadership and clinical operations experience to support Alnylam's oversight of CRO monitoring effectiveness. The Ass...
1d
Job Type | Full Time |
Director, Regulatory Affairs, CMC - Combination Products
Cambridge, Massachusetts
Work_Category - hybrid Description Overview The Director, RA CMC Combination Products will work cross-functionally to lead development and implementation of global combination product/Medical Devices regulatory strategies across all applica...
1d
Job Type | Full Time |
Associate Director, Supply Chain
Cambridge, Massachusetts
Work_Category - hybrid Description Overview This position is responsible for the management and oversight of end to end clinical supply chain activity for assigned clinical protocols. This position works closely with key stake holders inclu...
1d
Job Type | Full Time |
Business Account Executive, TTR: Chicago North
Cambridge, Massachusetts
Work_Category - virtual Description Overview We are looking for experienced Business Account Executives (BAEs) with rare disease experience to promote ONPATTRO (patisiran) in the U.S. ONPATTRO was approved in August 2018 by the FDA for the ...
1d
Job Type | Full Time |
Cambridge, Massachusetts
Work_Category - hybrid Description Overview The intern in the Epidemiology group will serve to learn the process of drug development where Epidemiologist can add value. This will include identifying incidence and prevalence figures for both...
1d
Job Type | Intern |
Cambridge, Massachusetts
Work_Category - hybrid Description Overview The Vice President, Study Management is a study management and execution subject matter expert and accountable for the delivery of studies within the assigned portfolio. The Vice President, Study ...
1d
Job Type | Full Time |